Company Vivos Therapeutics, Inc.
Equities
VVOS
US92859E2072
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.59 USD | 0.00% | -1.89% | -79.18% |
Apr. 01 | Signs of Softening Inflation Fuel Narrow Premarket Gains for US Equity Futures | MT |
Apr. 01 | Top Premarket Decliners | MT |
Business Summary
Number of employees: 119
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Oral Appliances and Therapeutic Treatments
100.0
%
| 16 | 100.0 % | 14 | 100.0 % | -13.87% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 16 | 100.0 % | 14 | 100.0 % | -13.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Huntsman
FOU | Founder | - | 16-07-06 |
RaeAnn Byrnes
FOU | Founder | - | 16-07-06 |
Susan McCullough
FOU | Founder | - | 16-07-06 |
R. Huntsman
CEO | Chief Executive Officer | 66 | 16-07-06 |
Bradford Amman
DFI | Director of Finance/CFO | 62 | 18-09-30 |
Neil Kline
CTO | Chief Tech/Sci/R&D Officer | 51 | - |
Julie Gannon
IRC | Investor Relations Contact | - | - |
Patrick Kircher
SAM | Sales & Marketing | - | - |
Ruth Hembree
PRN | Corporate Officer/Principal | - | - |
Nick DeGennaro
PRN | Corporate Officer/Principal | - | 19-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Leonard Sokolow
BRD | Director/Board Member | 67 | 20-05-31 |
Mark Lindsay
BRD | Director/Board Member | 61 | 20-05-31 |
Anja Krammer
BRD | Director/Board Member | 56 | 20-05-31 |
Ralph Green
BRD | Director/Board Member | 84 | 20-05-31 |
R. Huntsman
CEO | Chief Executive Officer | 66 | 16-07-06 |
Matthew Thompson
BRD | Director/Board Member | 62 | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,982,270 | 2,529,421 ( 84.82 %) | 0 | 84.82 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-79.18% | 7.72M | |
+72.92% | 12.36B | |
-19.68% | 7.83B | |
+16.20% | 7.21B | |
+4.77% | 5.97B | |
+7.49% | 5.14B | |
+23.97% | 4.43B | |
-18.81% | 3.9B | |
-41.54% | 2.2B | |
+1.61% | 2.02B |
- Stock Market
- Equities
- VVOS Stock
- Company Vivos Therapeutics, Inc.